Delphian Therapeutics
1 known investors
Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Delphian Therapeutics do?
- Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
- Who are Delphian Therapeutics's investors?
- Delphian Therapeutics's investors include 2Flo Ventures.